Nectin-4 binding agents
US-2025297004-A1 · Sep 25, 2025 · US
This page is not indexed by search engines while we improve data quality.
Rossi Benjamin patents
Rossi Benjamin is listed as an inventor on 61 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Rossi Benjamin |
| Total patents | 61 |
| First publication | Aug 20, 2015 |
| Latest publication | Sep 25, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Compositions and methods for treating cancer
US-2025236678-A1 · Jul 24, 2025 · US
Multispecific nk engager protein
US-2025215107-A1 · Jul 3, 2025 · US
Multispecific NK engager protein
US-12252543-B2 · Mar 18, 2025 · US
Nucleic acids encoding and methods of producing proteins comprising antibody chains
US-12202907-B2 · Jan 21, 2025 · US
Multispecific antibodies binding to cd20, nkp46, cd16 and conjugated to il-2
US-2025002601-A1 · Jan 2, 2025 · US
Treatment of cancer
US-2024325557-A1 · Oct 3, 2024 · US
Treatment of cancer with ilt-2 inhibitors
US-2024294634-A1 · Sep 5, 2024 · US
Variable regions for nkp46 binding proteins
US-2024174748-A1 · May 30, 2024 · US
MULTISPECIFIC NKp46 BINDING PROTEINS
US-2024141042-A1 · May 2, 2024 · US
Recent patents
Latest publications not already listed above.
Kir3dl2 binding agents
US-2024124579-A1 · Apr 18, 2024 · US
Immunohistochemistry methods and kir3dl2-specific reagents
US-2024117042-A1 · Apr 11, 2024 · US
Variable regions for NKp46 binding proteins
US-11891444-B2 · Feb 6, 2024 · US
KIR3DL2 binding agents
US-11858990-B2 · Jan 2, 2024 · US
NKp46 binding proteins
US-11845795-B2 · Dec 19, 2023 · US
Compositions and methods for treating cancer
US-2023340143-A1 · Oct 26, 2023 · US
Siglec-9-neutralizing antibodies
US-11623954-B2 · Apr 11, 2023 · US
Restoration of t cell activity via the cd39/cd73 axis
US-2023099801-A1 · Mar 30, 2023 · US
Combination therapy using antibody to human siglec-9 and antibody to human nkg2a for treating cancer
US-2023085847-A1 · Mar 23, 2023 · US
Compositions and methods for treating cancer
US-11578136-B2 · Feb 14, 2023 · US
Compositions and methods for treating cancer
US-2023025732-A1 · Jan 26, 2023 · US
Combination therapy using antibody to human Siglec-9 and antibody to human NKG2A for treating cancer
US-11447545-B2 · Sep 20, 2022 · US
MULTIFUNCTIONAL NATURAL KILLER (NK) CELL ENGAGERS BINDING TO NKp46 AND CD123
US-2022213202-A1 · Jul 7, 2022 · US
Antibodies that bind human CD39 and inhibit ATPase activity of a soluble extracellular domain human CD39 polypeptide
US-11377503-B2 · Jul 5, 2022 · US
Multispecific antigen binding proteins
US-2022135676-A1 · May 5, 2022 · US
Multispecific NK engager protein
US-11267897-B2 · Mar 8, 2022 · US
Compounds and methods for treatment of head and neck cancer
US-2022025045-A1 · Jan 27, 2022 · US
Leucocyte immunoglobulin-like receptor neutralizing antibodies
US-2022025056-A1 · Jan 27, 2022 · US
Multispecific antigen binding proteins
US-11208480-B2 · Dec 28, 2021 · US
Siglec neutralizing antibodies
US-2021363249-A1 · Nov 25, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Innate Pharma | 60 |
| Orega Biotech | 5 |
| Innate Pharma | 1 |
| Anfossi Nicolas | 1 |
| Gauthier Laurent | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 58 |
| C07K16/2803 | 50 |
| C07K2317/92 | 46 |
| C07K2317/565 | 37 |
| C07K2317/34 | 29 |